Debridement — the removal of necrotic, devitalized, or contaminated tissue from a wound bed — is widely regarded as a cornerstone of diabetic foot ulcer (DFU) management. By converting a chronic, biologically stalled wound into a more acute-appearing one, debridement is thought to reduce bioburden, eliminate senescent cells, and re-initiate the proliferative phase of healing. The comparative evidence supporting specific debridement methods and frequencies has been clarified by recent systematic reviews, network meta-analyses, and updated international guidelines.
Why Debridement Matters in the Diabetic Foot
Chronic DFUs frequently contain hyperkeratotic callus, fibrin slough, biofilm, and non-viable tissue that physically and biochemically obstruct re-epithelialization. Removing this material exposes healthy granulation tissue, decreases bacterial burden, and allows topical therapies to contact a viable wound bed. The 2023 update of the International Working Group on the Diabetic Foot (IWGDF) wound-healing guideline reaffirms that regular debridement with a scalpel or curette is part of standard care for nearly every DFU and should precede consideration of adjunctive therapies (Chen et al., 2024).
Comparing Debridement Techniques
Sharp (Surgical) Debridement
Sharp debridement, performed at the bedside or clinic with a scalpel, curette, or scissors, is the most widely studied and recommended method. A meta-analysis by Elraiyah and colleagues in the Journal of Vascular Surgery found sharp debridement was associated with significantly higher rates of complete wound closure than conservative care, and that surgically debrided ulcers healed faster (Elraiyah et al., 2016). A 2023 network meta-analysis similarly ranked sharp and surgical debridement among the most effective approaches for promoting DFU healing (Dong et al., 2023).
Ultrasound-Assisted Debridement
Low-frequency ultrasonic debridement uses a saline-irrigated probe to deliver acoustic energy that disrupts necrotic tissue and biofilm while sparing viable tissue. A 2024 meta-analysis of 11 randomized controlled trials including 696 participants found that ultrasound-assisted debridement was associated with significantly higher healing rates and shorter time to healing than standard care (Zhang et al., 2024). A 2025 meta-analysis in the World Journal of Diabetes reached comparable conclusions, though protocol heterogeneity and the need for larger trials were noted (Liu et al., 2025).
Enzymatic, Autolytic, Biosurgical, and Hydrosurgical Methods
Enzymatic debridement (most commonly with clostridial collagenase), autolytic debridement using moisture-retentive dressings, biosurgical debridement with sterile larvae, and hydrosurgical debridement have all been evaluated in DFUs. The IWGDF 2023 guideline concluded that current evidence does not support the use of autolytic, biosurgical, hydrosurgical, chemical, or laser debridement in preference to standard sharp debridement, though these methods may be reasonable adjuncts when sharp debridement is impossible or contraindicated (Chen et al., 2024). The 2024 Wound Healing Society guideline update reached a similar conclusion, identifying sharp debridement as the reference standard (Lavery et al., 2024).
How Often Should DFUs Be Debrided?
The optimal interval between debridements has long been debated. The prospective Diabetes Debridement Study, a multicentre randomized trial of 122 participants with plantar neuropathic DFUs, found no significant difference in healing outcomes at 12 weeks between ulcers debrided weekly and those debrided every second week (Lazzarini et al., 2021). The investigators concluded that while individual wound and patient factors may justify more frequent debridement, every-second-week debridement is a reasonable schedule when weekly visits are impractical, with potential benefits for resource utilization.
Choosing a Strategy in Clinical Practice
Current evidence supports several practical principles. Sharp debridement, performed by a clinician trained in DFU care, remains the first-line method for most plantar neuropathic ulcers. Adequate vascular assessment is essential before aggressive sharp debridement of an ischemic or neuro-ischemic ulcer, as removing tissue from a poorly perfused wound can worsen outcomes. Ultrasound-assisted debridement is an evidence-supported adjunct that may be useful for biofilm-laden or difficult-to-access wounds, while enzymatic and autolytic methods retain a role for selected patients in whom sharp debridement is unsuitable.
Conclusion
Debridement is one of the most consistently endorsed components of evidence-based diabetic foot ulcer care, but the choice of technique and frequency should be individualized. Sharp debridement remains the reference standard, supported by meta-analyses and by the IWGDF 2023 and WHS 2024 guidelines. Ultrasound-assisted debridement is an increasingly well-supported adjunct, while autolytic, enzymatic, biosurgical, and hydrosurgical approaches occupy more limited roles. Randomized data also suggest every-second-week debridement may achieve outcomes comparable to weekly debridement in stable plantar neuropathic ulcers — an important consideration as health systems strive to deliver high-quality wound care efficiently.
References
- Chen P, Vilorio NC, Dhatariya K, et al. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3644.
- Elraiyah T, Domecq JP, Prutsky G, et al. A systematic review and meta-analysis of debridement methods for chronic diabetic foot ulcers. Journal of Vascular Surgery. 2016;63(2 Suppl):37S-45S.
- Lavery LA, Barnes SA, Keith MS, et al. WHS (Wound Healing Society) guidelines update: Diabetic foot ulcer treatment guidelines. Wound Repair and Regeneration. 2024;32(1):34-58.
- Dong J, Chen L, Zhang Y, et al. Comparison of healing effectiveness of different debridement approaches for diabetic foot ulcers: a network meta-analysis of randomized controlled trials. Frontiers in Public Health. 2023;11:1271706.
- Lazzarini PA, Cramb SM, van Netten JJ, et al. A randomized trial comparing weekly with every second week sharp debridement in people with diabetes-related foot ulcers shows similar healing outcomes: potential benefit to resource utilization. Diabetes Care. 2021;44(12):e203-e205.
- Zhang J, Hu W, Diao Q, et al. Efficacy and safety of ultrasound-assisted wound debridement in the treatment of diabetic foot ulcers: a systematic review and meta-analysis of 11 randomized controlled trials. Frontiers in Endocrinology. 2024;15:1393251.
- Liu Y, Wang H, Li X, et al. Evaluating the effectiveness of ultrasound-assisted wound debridement in managing diabetic foot ulcers: A systematic review and meta-analysis. World Journal of Diabetes. 2025;16(2):97077.
Comments
